Welcome to LookChem.com Sign In|Join Free
  • or
4H-thieno[3,2-b]pyrrole-2-carboxylic acid is a heterocyclic organic compound characterized by a thienopyrrole ring system, which consists of a thiophene and a pyrrole ring fused together. 4H-thieno[3,2-b]pyrrole-2-carboxylic acid has the molecular formula C7H5NO2S and a molecular weight of 163.18 g/mol. It is a white crystalline solid with a melting point of 220-222°C. The carboxylic acid functional group (-COOH) is present at the 2-position of the thienopyrrole ring, which can participate in various chemical reactions, such as esterification, amidation, and peptide bond formation. Due to its unique structure, 4H-thieno[3,2-b]pyrrole-2-carboxylic acid has potential applications in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.

1007386-84-6

Post Buying Request

1007386-84-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1007386-84-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1007386-84-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,3,8 and 6 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1007386-84:
(9*1)+(8*0)+(7*0)+(6*7)+(5*3)+(4*8)+(3*6)+(2*8)+(1*4)=136
136 % 10 = 6
So 1007386-84-6 is a valid CAS Registry Number.

1007386-84-6Downstream Products

1007386-84-6Relevant academic research and scientific papers

THIENOPYRROLE DERIVATIVES AS ITK INHIBITORS

-

, (2014/04/03)

The present invention is directed to thienopyrrole compounds of formula (I) as Tec kinase inhibitors, in particular ITK (interleukin-2 inducible tyrosine kinase) inhibitors. Also provided herein are processes for preparing compounds described herein, inte

FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE

-

Page/Page column 83, (2008/06/13)

This invention provides novel inhibitors of the enzyme D-amino acid oxidase as well as pharmaceutical compositions including the compounds of the invention. The invention also provides methods for the treatment and prevention of neurological disorders, such as neuropsychiatric and neurodegenerative diseases, as well as pain, ataxia and convulsion. The compounds of the invention have the general structure: wherein A is NH or S. Q is a member selected from CR1 and N. X and Y are members independently selected from O, S, CR2, N and NH. R1, R2 and R4 are members independently selected from H and F, provided that at least one member selected from R1, R2 and R4 is F. R6 is a member selected from O?X+ and OH, wherein X+ is a positive ion, which is a member selected from inorganic positive ions and organic positive ions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1007386-84-6